Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnostic Test Kit Offers Easy Identification of Virulent Pathogens

By LabMedica International staff writers
Posted on 12 Jan 2017
A technology gap associated with commercially available diagnostic tests in remote and underdeveloped regions prevents timely pathogen identification for effective antibiotic chemotherapies for infected patients.

A portable detection system has been developed that can rapidly identify some of the most virulent, often multi-drug resistant pathogens. More...
This device was designed to be used in places where laboratory resources are lacking, such as isolated villages in developing countries.

An international team of scientists led by those from the University of Wisconsin-Madison developed a new battery powered detection system which is small and simple. Sixteen microchambers each contain a genetic sequence from one of the sixteen pathogens the device is designed to detect. When one of these sequences matches a sequence from a patient sample, a fluorescent light illuminates from within the relevant microchamber.

The investigators picked the sequences the device uses by screening the genomes of the relevant bacteria for unique genetic sequences. Pathogens can be identified using single drops of patient samples from blood, urine, or other bodily fluids. The system can identify Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and various species of the genus, Enterobacter.

To perform Recombinase Polymerase Amplification (RPA) assays in the B-chip, the team added the isothermal RPA mix including species specific primers, fluorescent exoprobe, and buffer to the TwistAmp exo kit lyophilized enzyme pellet using the TwistDX protocol. The investigators used microplate assays to assess the performance of RPA assays for detecting E. faecium, S. aureus, K. pneumoniae, A. baumannii, and P. aeruginosa. This very sensitive assay can provide positive identification with patient samples containing as few as 10 DNA sequences. They designed a portable B-chip detection system for measuring assay fluorescence containing an excitation source, camera, incubation heater, fluorescence filters and software to control the individual components.

The authors concluded that the combination of a simple and portable cartridge-based RPA assays and a versatile electronic reader that can be used to perform assays in the field. Using de-gas driven cartridges provides a unique platform for packaging RPA assays that can simplify their use and potentially reduce contamination by packaging and compartmentalization. The study was published on December 16, 2016, in the journal Applied and Environmental Microbiology.


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.